116 related articles for article (PubMed ID: 38897704)
1. Use of electronic health records for the management of diabetes and its risk factors in the Principality of Asturias from 2014 to 2018.
García-Villarino M; Lambert C; De la Hera JM; Torre ELM; Rodríguez-Lacín JMF; Delgado-Álvarez E
Endocrinol Diabetes Nutr (Engl Ed); 2024 May; 71(5):208-215. PubMed ID: 38897704
[TBL] [Abstract][Full Text] [Related]
2. Population and methodology of the SIMETAP study: Prevalence of cardiovascular risk factors, cardiovascular diseases, and related metabolic diseases.
Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; Morales-Cobos LE; García-Fernández ME; de la Peña-Antón N; Martín Calle MC; Díez Pérez MC; Montero Costa A; Palacios Martínez D; García Villasur MP; García Granado MAD; Lorenzo Borda MS; Cique Herráinz JA; Marañón Henrich N; Zarzuelo Martín N; Baltuille Aller MDC; Casaseca Calvo TF; Arribas Álvaro P; Macho Del Barrio AI; Moreno Fernández JC; Ribot Catalá C; Capitán Caldas M; Ciria de Pablo C; Sanz Velasco C; Simonaggio Stancampiano P; Vargas-Machuca Cabañero C; Sarriá Sánchez MT; Gómez Díaz E; Sanz Pozo B; Rodríguez de Mingo E; Cabello Igual MP; Rico Pérez MR; Migueláñez Valero A; Alcaraz Bethencourt A; Zafra Urango C; Chao Escuer P; Redondo de Pedro S; Escamilla Guijarro N; López Uriarte B; Rivera Teijido M;
Clin Investig Arterioscler; 2018; 30(5):197-208. PubMed ID: 29980384
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of cardiovascular disease and risk factors in a type 2 diabetic population of the North Catalonia diabetes study.
Jurado J; Ybarra J; Solanas P; Caula J; Gich I; Pou JM; Romeo JH
J Am Acad Nurse Pract; 2009 Mar; 21(3):140-8. PubMed ID: 19302689
[TBL] [Abstract][Full Text] [Related]
4. [Characteristics and cardiovascular events in a general population included in the RICARTO (RIesgo CARdiovascular TOledo) study: Data from the first 1,500 individuals included in the study].
Rodríguez-Roca GC; Segura-Fragoso A; Villarín-Castro A; Alonso-Moreno FJ; Rodríguez-Padial L; Rodríguez-García ML; Fernández-Conde JA; Rojas-Martelo GA; Menchén-Herreros A; Escobar-Cervantes C; Fernández-Martín J; Artigao-Rodenas LM; Carbayo-Herencia JA; Hernández-Moreno J;
Semergen; 2018 Apr; 44(3):180-191. PubMed ID: 28869129
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of diabetes mellitus in Spanish primary care setting and its association with cardiovascular risk factors and cardiovascular diseases. SIMETAP-DM study.
Ruiz-García A; Arranz-Martínez E; García-Álvarez JC; García-Fernández ME; Palacios-Martínez D; Montero-Costa A; Ciria-de-Pablo C; López-Uriarte B; García-Pliego RA; Chao-Escuer P; Zafra-Urango C; Alcaraz-Bethencourt A; Redondo-de-Pedro S; Escamilla-Guijarro N; Pascual-Val T; Vieira-Pascual MC; Martínez-Irazusta J; Martínez-Cid-de-Rivera E; Rodríguez-de-Cossío Á; de-Prado-Prieto L; Adrián-Sanz M; Minguela-Puras ME; Blanco-Canseco JM; Rubio-Villar M; Berbil-Bautista ML; Hueso-Quesada R; Plata-Barajas MT; Redondo-Sánchez M; Durán-Tejada MR; García-Redondo MR; Sánchez-Herráiz M; Rey-López AM; García-García-Alcañiz MP; Abad-Schilling C; Hidalgo-Calleja Y; Rivera-Teijido M;
Clin Investig Arterioscler; 2020; 32(1):15-26. PubMed ID: 31130360
[TBL] [Abstract][Full Text] [Related]
6. Clinical characteristics and degree of cardiovascular risk factor control in patients with newly-diagnosed type 2 diabetes in Catalonia.
Ramírez-Morros A; Franch-Nadal J; Real J; Miró-Catalina Q; Bundó M; Vlacho B; Mauricio D
Front Endocrinol (Lausanne); 2024; 15():1339879. PubMed ID: 38390201
[TBL] [Abstract][Full Text] [Related]
7. Metabolic control and cardiovascular risk factors in type 2 diabetes mellitus patients according to diabetes duration.
Franch-Nadal J; Roura-Olmeda P; Benito-Badorrey B; Rodriguez-Poncelas A; Coll-de-Tuero G; Mata-Cases M;
Fam Pract; 2015 Feb; 32(1):27-34. PubMed ID: 25194144
[TBL] [Abstract][Full Text] [Related]
8. [PREVENCAT study: control of cardiovascular risk in primary care].
Alvarez-Sala LA; Suárez C; Mantilla T; Franch J; Ruilope LM; Banegas JR; Barrios V;
Med Clin (Barc); 2005 Mar; 124(11):406-10. PubMed ID: 15799845
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of diabetes, epidemiological characteristics and vascular complications.
Russo MP; Grande-Ratti MF; Burgos MA; Molaro AA; Bonella MB
Arch Cardiol Mex; 2023; 93(1):30-36. PubMed ID: 36757785
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of atherogenic dyslipidemia in primary care patients at moderate-very high risk of cardiovascular disease. Cardiovascular risk perception.
Plana N; Ibarretxe D; Cabré A; Ruiz E; Masana L
Clin Investig Arterioscler; 2014; 26(6):274-84. PubMed ID: 24931442
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Dyslipidaemia Using an Algorithm of Lipid Profile Measures among Newly Diagnosed Type II Diabetes Mellitus Patients: A Cross-Sectional Study at Dormaa Presbyterian Hospital, Ghana.
Anto EO; Obirikorang C; Annani-Akollor ME; Adua E; Donkor S; Acheampong E; Asamoah EA
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31330902
[No Abstract] [Full Text] [Related]
12. Prevalence and control of type 2 diabetes mellitus among primary care physicians in Spain. PRISMA Study.
Franch-Nadal J; Mediavilla-Bravo J; Mata-Cases M; Mauricio D; Asensio D; Sarroca J
Endocrinol Diabetes Nutr; 2017 May; 64(5):265-271. PubMed ID: 28495322
[TBL] [Abstract][Full Text] [Related]
13. Relationship between glycaemic control and lipid profile in type 2 diabetes mellitus patients in a low-resource setting.
Nnakenyi ID; Nnakenyi EF; Parker EJ; Uchendu NO; Anaduaka EG; Ezeanyika LU
Pan Afr Med J; 2022; 41():281. PubMed ID: 35855025
[TBL] [Abstract][Full Text] [Related]
14. [Cardiovascular risk factors in Algeria. Analysis of the subgroup from the "Africa/Middle East Cardiovascular Epidemiological" Study].
Brouri M; Ouadahi N; Nibouche D; Benabbas Y; El Hassar M; Bouraoui S; Abad N; Abreu PC; Ikardouchene L
Ann Cardiol Angeiol (Paris); 2018 Apr; 67(2):61-66. PubMed ID: 29530274
[TBL] [Abstract][Full Text] [Related]
15. Increased prevalence of cardiovascular risk factors in children and adolescents with type 1 diabetes and hypertension: The SWEET international database.
Vazeou A; Tittel SR; Kordonouri O; Birkebaek NH; Iotova V; Piccini B; Seget S; Guness PK; Maahs DM; Stergiou GS
Diabetes Obes Metab; 2022 Dec; 24(12):2420-2430. PubMed ID: 36089908
[TBL] [Abstract][Full Text] [Related]
16. [Level at which control objectives are reached in patients in different population groups with type 2 diabetes].
Herrero A; Pinillos J; Sabio P; Martín JL; Garzón G; Gil Á
Semergen; 2017; 43(8):550-556. PubMed ID: 27889132
[TBL] [Abstract][Full Text] [Related]
17. Population prevalence and control of cardiovascular risk factors: what electronic medical records tell us.
Catalán-Ramos A; Verdú JM; Grau M; Iglesias-Rodal M; del Val García JL; Consola A; Comin E;
Aten Primaria; 2014 Jan; 46(1):15-24. PubMed ID: 24325864
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic inertia in the management of dyslipidaemia and hypertension in incident type 2 diabetes and the resulting risk factor burden: Real-world evidence from primary care.
Ling JZJ; Montvida O; Khunti K; Zhang AL; Xue CC; Paul SK
Diabetes Obes Metab; 2021 Jul; 23(7):1518-1531. PubMed ID: 33651456
[TBL] [Abstract][Full Text] [Related]
19. The burden of cardiovascular morbidity in a European Mediterranean population with multimorbidity: a cross-sectional study.
Violán C; Bejarano-Rivera N; Foguet-Boreu Q; Roso Llorach A; Pons-Vigués M; Martin Mateo M; Pujol-Ribera E
BMC Fam Pract; 2016 Nov; 17(1):150. PubMed ID: 27809772
[TBL] [Abstract][Full Text] [Related]
20. [Blood glucose control and cardiovascular risk factors in type 2 diabetic patients with cardiovascular disease in Spain, and its treatment pattern, according to gender: CODICE study].
Gómez García MC; Franch-Nadal J; Millaruelo Trillo JM; Cos-Claramunt FX; Avila Lachica L; Buil Cosiales P
Semergen; 2020 Mar; 46(2):125-135. PubMed ID: 31399388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
